Plasma cell membrane glycoprotein-1 K121Q polymorphism in preeclampsia

Gynecol Obstet Invest. 2006;61(3):124-7. doi: 10.1159/000089482. Epub 2005 Nov 2.

Abstract

Background: Preeclampsia is a common hereditary disease with unclear aetiology and various genetic and environmental components. We wanted to determine whether genetic variability in the gene encoding plasma cell membrane glycoprotein-1 (PC-1) contributes to individual susceptibility to the development of preeclampsia.

Methods: The case-control study involved 133 women with preeclampsia and 115 healthy controls. They were genotyped for the K121Q polymorphism in the PC-1 gene. chi(2) analysis was used to assess genotype and allele frequency differences between preeclamptic and control women.

Results: The frequency of the PC-1 gene 121K allele was found to be equal in the two groups, being 90.2% among women with preeclampsia and 90.4% among controls (p = 0.937; OR = 1.024; 95% CI = 0.564-1.861). Also the genotype distribution of the PC-1 K121Q polymorphism was similar (p = 0.516) in the preeclamptic and control groups.

Conclusions: The K121Q polymorphism of the PC-1 gene is unlikely to be a major genetic factor predisposing to preeclampsia in Finnish women.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Finland / epidemiology
  • Gene Frequency
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease
  • Genotype
  • Glutamine
  • Humans
  • Lysine
  • Phosphoric Diester Hydrolases / genetics*
  • Polymorphism, Genetic*
  • Pre-Eclampsia / genetics*
  • Pregnancy
  • Pyrophosphatases / genetics*

Substances

  • Genetic Markers
  • Glutamine
  • Phosphoric Diester Hydrolases
  • ectonucleotide pyrophosphatase phosphodiesterase 1
  • Pyrophosphatases
  • Lysine